
Last Price
52 Week Range
$26.74 - $46.60
Next Earnings Date
Feb 26 2026 (Estimate)
Next Earnings Date
Feb 26 2026 (Est.)
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Xenon Pharmaceuticals Inc. | 8-K | December 1, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | November 3, 2025 | |
Xenon Pharmaceuticals Inc. | 10-Q | November 3, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | October 16, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | August 11, 2025 | |
Xenon Pharmaceuticals Inc. | 10-Q | August 11, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | July 3, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | June 5, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | May 12, 2025 | |
Xenon Pharmaceuticals Inc. | 10-Q | May 12, 2025 | |
Xenon Pharmaceuticals Inc. | ARS | April 24, 2025 | |
Xenon Pharmaceuticals Inc. | DEF 14A | April 24, 2025 | |
Xenon Pharmaceuticals Inc. | DEFA14A | April 24, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | March 17, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | March 5, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | February 27, 2025 | |
Xenon Pharmaceuticals Inc. | 10-K | February 27, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | January 17, 2025 | |
Xenon Pharmaceuticals Inc. | 8-K | November 12, 2024 | |
Xenon Pharmaceuticals Inc. | 10-Q | November 12, 2024 | |
Xenon Pharmaceuticals Inc. | S3ASR | August 9, 2024 | |
Xenon Pharmaceuticals Inc. | 10-Q | August 8, 2024 | |
Xenon Pharmaceuticals Inc. | 8-K | August 8, 2024 | |
Xenon Pharmaceuticals Inc. | 8-K | June 5, 2024 | |
Xenon Pharmaceuticals Inc. | 10-Q | May 9, 2024 | |
Xenon Pharmaceuticals Inc. | 8-K | May 9, 2024 | |
Xenon Pharmaceuticals Inc. | DEF 14A | April 26, 2024 | |
Xenon Pharmaceuticals Inc. | ARS | April 26, 2024 | |
Xenon Pharmaceuticals Inc. | 8-K | April 19, 2024 | |
Xenon Pharmaceuticals Inc. | 8-K | March 8, 2024 |
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.